Telcagepant: a new option for migraine treatment

8 December 2008 Print this article Comments Share this article
An oral calcitonin-gene-related peptide (CGRP) receptor antagonist, telcagepant, has been shown to have a similar efficacy in treating migraine as zolmitriptan, but with fewer side-effects....

Want to read complete article? Please Sign in or Register.